CONTEXT: Understanding the epidemiology and risk factors for non–muscle invasive
bladder cancer (NMIBC) can assist in the prevention and early detection of the disease …

OBJECTIVES: In 1998, a revised system of classifying noninvasive papillary urothelial
neoplasms of the urinary bladder was proposed and subsequently formally adopted by the …

In urothelial bladder cancer (UBC), risk stratification remains an important unmet need.
Limitless self‐renewal, governed by TERT expression and telomerase activation, is crucial …

BACKGROUND Urothelial carcinoma of the bladder often contains areas with different
histologic grades. The influence of cancer heterogeneity on grading and its relation to …

Summary The Gleason Grading system has been used for over 50 years to prognosticate
and guide the treatment for patients with prostate cancer. At consensus conferences in 2005 …

The aim of this study was to assess the relationship of immunoreactivity of cytokeratin 20
(CK20) and CD44 across the spectrum of urothelial neoplasia using the WHO/ISUP …

A urine sample preparation workflow for the iTRAQ (isobaric tag for relative and absolute
quantitation) technique was established. The reproducibility of this platform was evaluated …

PURPOSE: Docetaxel is a safe agent for intravesical therapy. Adding monthly maintenance
treatments can extend response durability. We report our cumulative experience with …

The “atypical urothelial cell” cytologic category is nonstandardized. We subclassify atypical
cases to “atypical, favor a reactive process” or “atypical, unclear if reactive or neoplastic.” We …

Aims: To investigate whether prognosis in micropapillary urothelial carcinoma is related to
the proportion of the micropapillary component (MPC), and to identify the …